Natalie K. Boyd

706 total citations
21 papers, 479 citations indexed

About

Natalie K. Boyd is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Natalie K. Boyd has authored 21 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 5 papers in Epidemiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Natalie K. Boyd's work include Antimicrobial Resistance in Staphylococcus (5 papers), Down syndrome and intellectual disability research (3 papers) and Antifungal resistance and susceptibility (3 papers). Natalie K. Boyd is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), Down syndrome and intellectual disability research (3 papers) and Antifungal resistance and susceptibility (3 papers). Natalie K. Boyd collaborates with scholars based in United States, Australia and Canada. Natalie K. Boyd's co-authors include Christopher R. Frei, Grace C. Lee, Chengwen Teng, Kelly R. Reveles, Michael D. Nailor, Krista L. Niece, Kevin S. Akers, Mark A. Frye, Mehmet F. Keleş and Jaison J. Omoto and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, eLife and Journal of Neurology.

In The Last Decade

Natalie K. Boyd

20 papers receiving 470 citations

Peers

Natalie K. Boyd

EPIDE

CCICM

Jon Femling United States

Satoshi Nakashio Japan

Saroj Sharma India

Mike Marvin Ruth Netherlands

L. Christophersen Denmark

Yiying Cai Singapore

Estelle Marcon France

William J. Novick United States

Bahman Mirzaei Iran

Isa Serrano Portugal

Jon Femling United States

Natalie K. Boyd

314 ×1.3

105 ×0.6

EPIDE

94 ×1.3

449 ×6.2

18 ×0.3

CCICM

Citations per year, relative to Natalie K. Boyd Natalie K. Boyd (= 1×) peers Jon Femling

Countries citing papers authored by Natalie K. Boyd

Since Specialization

Citations

This map shows the geographic impact of Natalie K. Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie K. Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie K. Boyd more than expected).

Fields of papers citing papers by Natalie K. Boyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie K. Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie K. Boyd. The network helps show where Natalie K. Boyd may publish in the future.

Co-authorship network of co-authors of Natalie K. Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie K. Boyd. A scholar is included among the top collaborators of Natalie K. Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie K. Boyd. Natalie K. Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Santoro, Jonathan D., Saba Jafarpour, Natalie K. Boyd, et al.. (2025). Evidence of blood–brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder. Annals of Clinical and Translational Neurology. 12(4). 805–820.

Santoro, Jonathan D., Saba Jafarpour, Natalie K. Boyd, et al.. (2024). Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorder. Annals of Clinical and Translational Neurology. 11(4). 1034–1045. 4 indexed citations

Boyd, Natalie K., et al.. (2024). Down Syndrome and Autoimmune Disease. Clinical Reviews in Allergy & Immunology. 66(3). 261–273. 5 indexed citations

Santoro, Jonathan D., Saba Jafarpour, Natalie K. Boyd, et al.. (2024). Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorder. American Journal of Medical Genetics Part A. 194(5). e63524–e63524. 1 indexed citations

Jafarpour, Saba, et al.. (2023). Impact of endocrine dysregulation on disability and non-motor symptoms in pediatric onset multiple sclerosis. Frontiers in Neurology. 14. 1304610–1304610. 1 indexed citations

Santoro, Jonathan D., et al.. (2023). The Impact of Neuroimmunologic Disease and Developing Nervous System. Pediatric Neurology. 148. 189–197. 1 indexed citations

Jafarpour, Saba, Abhik Banerjee, Natalie K. Boyd, et al.. (2022). Association of rare variants in genes of immune regulation with pediatric autoimmune CNS diseases. Journal of Neurology. 269(12). 6512–6529. 2 indexed citations

Boyd, Natalie K., Chengwen Teng, & Christopher R. Frei. (2021). Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing. Frontiers in Cellular and Infection Microbiology. 11. 684515–684515. 97 indexed citations

Omoto, Jaison J., et al.. (2021). A visual pathway for skylight polarization processing in Drosophila. eLife. 10. 69 indexed citations

10.

Boyd, Natalie K., Grace C. Lee, Chengwen Teng, & Christopher R. Frei. (2021). In vitro activity of non-antibiotic drugs against Staphylococcus aureus clinical strains. Journal of Global Antimicrobial Resistance. 27. 167–171. 15 indexed citations

11.

Lee, Grace C., Ronald G. Hall, Natalie K. Boyd, et al.. (2016). A prospective observational cohort study in primary care practices to identify factors associated with treatment failure in Staphylococcus aureus skin and soft tissue infections. Annals of Clinical Microbiology and Antimicrobials. 15(1). 58–58. 10 indexed citations

12.

Frei, Christopher R., et al.. (2016). Application of a Risk Score to Identify Older Adults with Community‐Onset Pneumonia Most Likely to Benefit From Empiric Pseudomonas Therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 37(2). 195–203. 2 indexed citations

13.

Lee, Grace C., Ronald G. Hall, Natalie K. Boyd, et al.. (2016). Predictors of community-associated Staphylococcus aureus, methicillin-resistant and methicillin-susceptible Staphylococcus aureus skin and soft tissue infections in primary-care settings. Epidemiology and Infection. 144(15). 3198–3204. 10 indexed citations

14.

Niece, Krista L., Natalie K. Boyd, & Kevin S. Akers. (2015). In Vitro Study of the Variable Effects of Proton Pump Inhibitors on Voriconazole. Antimicrobial Agents and Chemotherapy. 59(9). 5548–5554. 30 indexed citations

15.

Aitken, Samuel L, et al.. (2015). Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001-2010. American Journal of Infection Control. 43(5). 435–440. 24 indexed citations

16.

Boyd, Natalie K., et al.. (2015). Incidence and Cost of Skin and soft Tissue Infections In the united States. Value in Health. 18(3). A245–A245. 17 indexed citations

17.

Reveles, Kelly R., et al.. (2014). Regional And Seasonal Variations In Clostridium Difficile Infections In United States Hospitals, 2001 To 2010. Value in Health. 17(3). A267–A267. 1 indexed citations

18.

Reveles, Kelly R., Grace C. Lee, Natalie K. Boyd, & Christopher R. Frei. (2014). The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010. American Journal of Infection Control. 42(10). 1028–1032. 116 indexed citations

19.

Boyd, Natalie K., et al.. (2012). Utilization of Omeprazole To Augment Subtherapeutic Voriconazole Concentrations for Treatment of Aspergillus Infections. Antimicrobial Agents and Chemotherapy. 56(11). 6001–6002. 27 indexed citations

20.

Boyd, Natalie K. & Michael D. Nailor. (2011). Combination Antibiotic Therapy for Empiric and Definitive Treatment of Gram‐Negative Infections: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(11). 1073–1084. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact